Bandrone (Ibandronic 150mg)

Bandrone also known as Indian Generic BONIVA is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis.  

Limitations of Use

The optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use.

 Warning and Precautions:

Upper gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions and discontinue use if new or worsening symptoms occur.

Hypocalcemia may worsen during treatment. Correct hypocalcemia before use.

Severe Bone, Joint, and Muscle Pain may occur. Consider discontinuing use if symptoms develop.

Osteonecrosis of the Jaw has been reported.

Atypical Femur Fractures have been reported. Patients with new thigh or groin pain should be evaluated to rule out a femoral fracture.

 DRUG INTERACTIONS

The most common adverse reactions (greater than 5%) are back pain, dyspepsia, pain in extremity, diarrhea, headache, and myalgia.

Bandrone’s is a generic prescription medicine from Natco, which is one of the biggest pharmaceutical company in India.